Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
기간	3개월	3개월	3개월	3개월	3개월
Revenues	0.23%5.15	5.14	3.82	6.78	3.82
Gross Profit	3.47%2.95	3.06	2.99	3.94	2.11
Operating Expenses	19.60%7.78	9.67	9.37	8.67	6.98
Interest Income/Expense	1.10	1.10	0.80	0.50	-
Depreciation and Amortization	12.33%0.51	0.45	0.44	0.38	0.31
Operating Income/Loss	27.06%-4.83	-6.62	-6.38	-4.73	-4.87
Income/Loss From Continuing Operations Before Tax	28.74%-5.52	-7.75	-6.95	-5.40	-5.01
	28.74%-5.52	-7.75	-6.89	-5.40	-5.01
Attributable To Parent	28.65%-5.48	-7.68	-6.89	-5.40	-5.01
Available To Common Stockholders, Basic	28.65%-5.48	-7.68	-6.95	-5.40	-5.01
Attributable To Noncontrolling Interest	39.13%-0.04	-0.07	-	-	-
Basic Average Shares	20.83%17.68	14.63	-	10.96	9.09
Diluted Average Shares	20.83%17.68	14.63	-	10.96	9.09
Basic Earnings Per Share	40.38%-0.31	-0.52	-	-0.49	-0.55
Diluted Earnings Per Share	40.38%-0.31	-0.52	-	-0.49	-0.55